CIK 0000805928 · Electromedical & Electrotherapeutic Apparatus (SIC 3845) · Nasdaq · incorporated in MN · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 225.2 M | 138.6 M | ||
| Net income (USD) | -23.8 M | -29.1 M | ||
| Diluted EPS (USD/shares) | -0.34 | -0.69 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-02 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-10-01 | 8-K | FORM 8-K items 7.01,9.01 | 2026-10-01 |
| 2026-09-10 | 424B5 | 424B5 | |
| 2026-09-10 | 8-K/A | 8-K/A items 1.01,7.01,9.01 | 2026-09-09 |
| 2026-09-10 | 8-K | 8-K items 1.01,7.01,8.01,9.01 | 2026-09-09 |
| 2026-09-04 | 4 | FORM 4 | 2026-09-02 |
| 2026-09-02 | 144 | 144 | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | 4 | FORM 4 | 2026-08-10 |
| 2026-08-12 | 4 | FORM 4 | 2026-08-11 |
| 2026-08-11 | 144 | 144 | |
| 2026-08-11 | 4 | FORM 4 | 2026-08-07 |
| 2026-08-10 | 144 | 144 | |
| 2026-08-07 | 144 | 144 | |
| 2026-07-31 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-29 | 10-Q | FORM 10-Q | 2026-06-30 |
| 2026-07-29 | 8-K | FORM 8-K items 2.02,7.01,9.01 | 2026-07-29 |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-23 | 8-K | FORM 8-K items 5.07 | 2026-06-23 |
Forms on file (last 1,000): 4 536, 8-K 148, 144 48, 10-Q 36, SC 13G/A 34, 3 29, 4/A 28, SC 13G 16. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=AXGN (0.002 USD), /gw/filings/filings?ticker=AXGN&form=8-K, /gw/filings/facts?ticker=AXGN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange